Proteoglycan 4 (lubricin) is a highly sialylated glycoprotein associated with cardiac valve damage in animal models of infective endocarditis.


Journal

Glycobiology
ISSN: 1460-2423
Titre abrégé: Glycobiology
Pays: England
ID NLM: 9104124

Informations de publication

Date de publication:
18 12 2021
Historique:
received: 21 05 2021
revised: 30 07 2021
accepted: 16 08 2021
pubmed: 31 8 2021
medline: 18 3 2022
entrez: 30 8 2021
Statut: ppublish

Résumé

Streptococcus gordonii and Streptococcus sanguinis are primary colonizers of tooth surfaces and are generally associated with oral health, but can also cause infective endocarditis (IE). These species express "Siglec-like" adhesins that bind sialylated glycans on host glycoproteins, which can aid the formation of infected platelet-fibrin thrombi (vegetations) on cardiac valve surfaces. We previously determined that the ability of S. gordonii to bind sialyl T-antigen (sTa) increased pathogenicity, relative to recognition of sialylated core 2 O-glycan structures, in an animal model of IE. However, it is unclear when and where the sTa structure is displayed, and which sTa-modified host factors promote valve colonization. In this study, we identified sialylated glycoproteins in the aortic valve vegetations and plasma of rat and rabbit models of this disease. Glycoproteins that display sTa vs. core 2 O-glycan structures were identified by using recombinant forms of the streptococcal Siglec-like adhesins for lectin blotting and affinity capture, and the O-linked glycans were profiled by mass spectrometry. Proteoglycan 4 (PRG4), also known as lubricin, was a major carrier of sTa in the infected vegetations. Moreover, plasma PRG4 levels were significantly higher in animals with damaged or infected valves, as compared with healthy animals. The combined results demonstrate that, in addition to platelet GPIbα, PRG4 is a highly sialylated mucin-like glycoprotein found in aortic valve vegetations and may contribute to the persistence of oral streptococci in this protected endovascular niche. Moreover, plasma PRG4 could serve as a biomarker for endocardial injury and infection.

Identifiants

pubmed: 34459483
pii: 6357685
doi: 10.1093/glycob/cwab095
pmc: PMC8684468
doi:

Substances chimiques

Proteoglycans 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1582-1595

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI106987
Pays : United States
Organisme : NIH HHS
ID : R01AI139244
Pays : United States
Organisme : American Heart Association-American Stroke Association
ID : 17SDG33660424
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI130056
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Glycobiology. 2018 Aug 1;28(8):601-611
pubmed: 29796594
Infect Immun. 1987 Aug;55(8):1743-50
pubmed: 3112008
Br J Exp Pathol. 1972 Feb;53(1):44-9
pubmed: 5014243
J Clin Invest. 1984 Jun;73(6):1750-3
pubmed: 6427279
Microb Pathog. 2008 Oct;45(4):297-301
pubmed: 18656529
Biochem J. 2010 Jul 15;429(2):359-67
pubmed: 20443780
Infect Immun. 2006 Jan;74(1):740-3
pubmed: 16369032
Infect Immun. 2009 Nov;77(11):4966-75
pubmed: 19703977
Nat Rev Cardiol. 2014 Jan;11(1):35-50
pubmed: 24247105
PLoS Pathog. 2019 Jun 24;15(6):e1007896
pubmed: 31233555
Glycoconj J. 2001 Oct;18(10):807-15
pubmed: 12441670
J Thorac Cardiovasc Surg. 2018 Oct;156(4):1598-1608.e1
pubmed: 29859675
J Biol Chem. 2012 Oct 19;287(43):35922-33
pubmed: 22930755
J Surg Res. 2020 Sep;253:53-62
pubmed: 32320897
Cells. 2020 Mar 11;9(3):
pubmed: 32168892
Arthritis Rheumatol. 2015 Jun;67(6):1503-13
pubmed: 25708025
Infect Immun. 2002 Mar;70(3):1209-18
pubmed: 11854202
J Histochem Cytochem. 2016 Nov;64(11):647-668
pubmed: 27680668
Infect Immun. 2008 Jun;76(6):2551-9
pubmed: 18390999
J Neurotrauma. 2021 Feb 15;38(4):385-398
pubmed: 32940130
Diagn Microbiol Infect Dis. 2015 Apr;81(4):240-5
pubmed: 25616316
Circulation. 2020 Aug 25;142(8):720-730
pubmed: 32580572
JAMA Ophthalmol. 2013 Jun;131(6):766-76
pubmed: 23599181
Bioessays. 2019 Jan;41(1):e1800166
pubmed: 30485469
J Bacteriol. 2009 Jul;191(13):4166-79
pubmed: 19395487
PLoS Pathog. 2021 Jan 19;17(1):e1009222
pubmed: 33465168
Nat Rev Microbiol. 2014 Jan;12(1):49-62
pubmed: 24336184
Crit Care Explor. 2020 Jun 10;2(6):e0126
pubmed: 32695993
Infect Immun. 2006 Aug;74(8):4418-23
pubmed: 16861627
Cytogenet Cell Genet. 2000;90(3-4):291-7
pubmed: 11124536
Arthritis Res Ther. 2015 Dec 04;17:353
pubmed: 26643105
Sci Rep. 2016 Jan 11;6:18910
pubmed: 26752378
J Clin Microbiol. 2012 Mar;50(3):1039-42
pubmed: 22189124
Infect Immun. 2006 Mar;74(3):1933-40
pubmed: 16495569
FEMS Immunol Med Microbiol. 2006 Dec;48(3):390-9
pubmed: 17069618
Infect Immun. 2018 Dec 19;87(1):
pubmed: 30396893
J Infect Dis. 2012 Apr 1;205(7):1066-75
pubmed: 22357661
Mol Microbiol. 2014 Jun;92(6):1243-59
pubmed: 24750294
J Infect Dis. 2020 Sep 1;222(7):1188-1198
pubmed: 32333768
Glycobiology. 2016 Nov;26(11):1222-1234
pubmed: 27037304
Equine Vet J. 2017 Jan;49(1):116-123
pubmed: 26507102
Eur J Clin Microbiol Infect Dis. 2016 Oct;35(10):1615-25
pubmed: 27325438
Nat Rev Microbiol. 2006 Jun;4(6):445-57
pubmed: 16710325
Mol Cell. 2019 Jul 25;75(2):394-407.e5
pubmed: 31227230
Connect Tissue Res. 2008;49(5):311-20
pubmed: 18991084
Cell Microbiol. 2017 Jan;19(1):
pubmed: 27616700
Infect Immun. 2019 Sep 19;87(10):
pubmed: 31308084
Nat Commun. 2019 Oct 11;10(1):4656
pubmed: 31604940
Mol Microbiol. 2005 Oct;58(2):380-92
pubmed: 16194227
J Pediatric Infect Dis Soc. 2016 Mar;5(1):85-8
pubmed: 26908495
Infect Immun. 2008 Oct;76(10):4686-91
pubmed: 18678668
J Pathol. 1975 Feb;115(2):81-9
pubmed: 1151519
PLoS Pathog. 2014 Dec 04;10(12):e1004540
pubmed: 25474103
JCI Insight. 2020 Jul 23;5(14):
pubmed: 32544089
PLoS Pathog. 2011 Jul;7(7):e1002112
pubmed: 21765814
Br J Haematol. 2005 Apr;129(1):101-9
pubmed: 15801962
Infect Immun. 2016 Apr 22;84(5):1470-1477
pubmed: 26930704
J Thromb Haemost. 2020 May;18(5):995-1008
pubmed: 31925863

Auteurs

Kemal Solakyildirim (K)

Department of Chemistry, University of California, Davis, CA 95616, USA.
Department of Chemistry, Erzincan Binali Yildirim University, Erzincan 24100, Turkey.

Yi Li (Y)

Division of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.

Arnold S Bayer (AS)

Division of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Paul M Sullam (PM)

Department of Medicine, San Francisco Veterans Affairs Medical Center and University of California, San Francisco, CA 94121, USA.

Yan Q Xiong (YQ)

Division of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Carlito B Lebrilla (CB)

Department of Chemistry, University of California, Davis, CA 95616, USA.

Barbara A Bensing (BA)

Department of Medicine, San Francisco Veterans Affairs Medical Center and University of California, San Francisco, CA 94121, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH